New Delhi, Jan. 27 -- As cancer care increasingly shifts toward data-driven decision-making, 4baseCare is positioning itself at the intersection of genomics, AI, and clinical practice.

The Bengaluru-based precision oncology company has announced the first close of its Series B funding round, raising Rs.90 crore co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing investor Yali Capital. The funding marks the company's next phase of growth as it looks beyond India to scale its population-relevant clinico-genomic intelligence platform across multiple emerging markets.

4baseCare had earlier raised Rs.50 crore in a Series A round led by Yali Capital, with participation from Infosys.

At the core of 4baseCare's strat...